Table 3.
Outcomes of the 30-day follow-up study
| Outcomes | Cases (N = 20) |
|---|---|
| All-cause mortality (%) | 4 (20) |
| Cardiovascular mortality (%) | 4 (20) |
| Non-cardiovascular mortality (%) | 0 (0) |
| Coronary obstruction (%) | 2 (10) |
| Cardiac tamponade (%) | 2 (10) |
| Bleeding complications (%) | 0 (0) |
| Vascular complications (%) | 0 (0) |
| Conduction disturbances and arrhythmias (%) | 0 (0) |
| Myocardial infarction (%) | 0 (0) |
| Valve migration (%) | 0 (0) |
| Acute kidney injury | 0 (0) |
| Stroke | 0 (0) |
| Paravalvular leakage | – |
| Mild (%) | 6 (30) |
| Moderate (%) | 0 (0) |
| Severe (%) | 0 (0) |
Values are n (%)